Congresswoman To DEA: ‘Reject Any Argument’ That Marijuana Rescheduling Violates US Treaty Obligations

Rep. Sydney Kamlager-Dove (D-Calif.) urged the Drug Enforcement Administration (DEA) to refute any assertions that suggested rescheduling marijuana at the federal level would breach international treaty obligations. In a letter to DEA administrator Anne Milgram, Kamlager-Dove stressed international treaties neither mandate the inclusion of marijuana in Schedule I or II ... Read More

FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana

The Food and Drug Administration recently offered a glimpse into its comprehensive analysis justifying its recommendation to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. CDER director Patrizia Cavazzoni explained that as part of the FDA’s “directive to explore whether marijuana should remain listed as ... Read More

Ron DeSantis Questions Legitimacy Of Florida Medical Marijuana Users, Suggests “Pretext” For Recreational – Trulieve Cannabis (OTC:TCNNF)

Florida Governor Ron DeSantis cast doubt on the medical necessity of marijuana for at least some of the state’s 850,000 registered patients. While speaking to supporters this week in a lead-up to the Jan. 15 Iowa caucuses, the Republican presidential candidate suggested that some in Florida may be using the program as ... Read More